Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLG | P54098 | 2/20 | 0.49 |
| ▸ | P2RY2 | P41231 | 11/20 | 0.47 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.42 |
| ▸ | P2RY6 | Q15077 | 4/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15074337 | 1.00 | POLG (0.49) | POLGP2RY2P2RY4P2RY6POLB | |
| SCHEMBL17863916 | 1.00 | POLG (0.49) | POLGP2RY2P2RY4P2RY6POLB | |
| SCHEMBL15070576 | 1.00 | POLG (0.49) | POLGP2RY2P2RY4P2RY6POLB | |
| SCHEMBL17359383 | 1.00 | POLG (0.49) | POLGP2RY2P2RY4P2RY6POLB | |
| SCHEMBL17359385 | 0.98 | POLG (0.47) | POLGP2RY2P2RY4P2RY6POLB | |
| SCHEMBL17357643 | 0.98 | POLG (0.47) | POLGP2RY2P2RY4P2RY6POLB | |
| SCHEMBL17863952 | 0.92 | POLG (0.50) | POLGP2RY2P2RY4P2RY6POLB | |
| SCHEMBL17861901 | 0.92 | POLG (0.50) | POLGP2RY2P2RY4P2RY6POLB | |
| SCHEMBL15070639 | 0.92 | POLG (0.50) | POLGP2RY2P2RY4P2RY6POLB | |
| SCHEMBL16374023 | 0.92 | POLG (0.50) | POLGP2RY2P2RY4P2RY6POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3171878-A1 | METHODS FOR TREATING PARAMYXOVIRUSES | Alios Biopharma, Inc. (US) | 2017-05-31 | — | — | EP | disclosed |
| WO-2016014398-A1 | METHODS FOR TREATING PARAMYXOVIRUSES | ALIOS BIOPHARMA, INC. (US) | 2016-01-28 | — | — | WO | disclosed |